Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangpeng Dai

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Reproduction (Cambridge, England)|June 5, 2009
A modified culture method significantly improves the development of mouse somatic cell nuclear transfer embryosXiangpeng Dai, Jie Hao, Qi Zhou
Cell Cycle (Georgetown, Tex.)|November 8, 2017
SPOP-mediated degradation of BRD4 dictates cellular sensitivity to BET inhibitorsXiangpeng Dai, Zhiwei Wang, Wenyi Wei
Molecular Oncology|March 8, 2024
Advanced strategies in improving the immunotherapeutic effect of CAR-T cell therapyMinmin Wang, Linzi Jia, Xiangpeng Dai, et al.
Zygote (Cambridge, England)|December 6, 2012
Identification of four genes required for mammalian blastocyst formationMarc Maserati, Xiangpeng Dai, Melanie Walentuk, et al.
Reproductive Biology and Endocrinology : RB&E|April 14, 2026
Synthetic embryos: current progress, application and challengesLuyao Wang, Fucheng Guo, Yurong Chen, et al.
Cell Cycle (Georgetown, Tex.)|September 22, 2016
A new layer of degradation mechanism for PR-Set7/Set8 during cell cycleNana Zheng, Xiangpeng Dai, Zhiwei Wang, et al.
Frontiers in Immunology|August 12, 2022
CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironmentTong Zhang, Haixiang Yu, Xiangpeng Dai, et al.
Frontiers in Pharmacology|November 17, 2022
Deciphering the role of DOCK8 in tumorigenesis by regulating immunity and the application of nanotechnology in DOCK8 deficiency therapyLonghui Zhang, Yang Cao, Xiangpeng Dai, et al.
Frontiers in Immunology|October 12, 2023
Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume IINaoe Taira Nihira, Tomohiko Ohta, Zichuan Liu, et al.
Frontiers in Immunology|December 26, 2024
Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume IIIXuejing Zhao, Naoe Taira Nihira, Xiangpeng Dai, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Reproduction (Cambridge, England)|June 5, 2009
A modified culture method significantly improves the development of mouse somatic cell nuclear transfer embryosXiangpeng Dai, Jie Hao, Qi Zhou
Cell Cycle (Georgetown, Tex.)|November 8, 2017
SPOP-mediated degradation of BRD4 dictates cellular sensitivity to BET inhibitorsXiangpeng Dai, Zhiwei Wang, Wenyi Wei
Molecular Oncology|March 8, 2024
Advanced strategies in improving the immunotherapeutic effect of CAR-T cell therapyMinmin Wang, Linzi Jia, Xiangpeng Dai, et al.
Zygote (Cambridge, England)|December 6, 2012
Identification of four genes required for mammalian blastocyst formationMarc Maserati, Xiangpeng Dai, Melanie Walentuk, et al.
Reproductive Biology and Endocrinology : RB&E|April 14, 2026
Synthetic embryos: current progress, application and challengesLuyao Wang, Fucheng Guo, Yurong Chen, et al.
Cell Cycle (Georgetown, Tex.)|September 22, 2016
A new layer of degradation mechanism for PR-Set7/Set8 during cell cycleNana Zheng, Xiangpeng Dai, Zhiwei Wang, et al.
Frontiers in Immunology|August 12, 2022
CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironmentTong Zhang, Haixiang Yu, Xiangpeng Dai, et al.
Frontiers in Pharmacology|November 17, 2022
Deciphering the role of DOCK8 in tumorigenesis by regulating immunity and the application of nanotechnology in DOCK8 deficiency therapyLonghui Zhang, Yang Cao, Xiangpeng Dai, et al.
Frontiers in Immunology|October 12, 2023
Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume IINaoe Taira Nihira, Tomohiko Ohta, Zichuan Liu, et al.
Frontiers in Immunology|December 26, 2024
Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume IIIXuejing Zhao, Naoe Taira Nihira, Xiangpeng Dai, et al.
Pageof 10